Methotrexate

NDC 59651-182 · Aurobindo Pharma Limited

Generic nameMethotrexate

Dosage formTABLET

RouteORAL

Active ingredient(s)METHOTREXATE SODIUM

Strength2.5 mg/1

Pharmacologic classFolate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]

Marketing categoryANDA

Packages

59651-182-01 — 100 TABLET in 1 BOTTLE (59651-182-01)

59651-182-36 — 36 TABLET in 1 BOTTLE (59651-182-36)

J8610 — Methotrexate; oral, 2.5 mg Medicare Part B payment limit (ASP + 6%): $0.15

FDA lists these products with the same active ingredient.

55150-513 — METHOTREXATE, 59137-505 — methotrexate, 59137-510 — methotrexate, 59137-515 — methotrexate, 59137-520 — methotrexate, 59137-525 — methotrexate, 59137-530 — methotrexate, 59137-535 — methotrexate, 59137-540 — methotrexate, 59137-550 — methotrexate, 61703-124 — Methotrexate, 61703-161 — Methotrexate, 61703-350 — Methotrexate, 61703-408 — Methotrexate, 62135-772 — Methotrexate, 62332-711 — methotrexate, 62332-712 — methotrexate, 62332-730 — METHOTREXATE, 63323-122 — METHOTREXATE SODIUM, 63323-123 — METHOTREXATE SODIUM, +34 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.